• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Monday

    5/22/23 12:08:16 PM ET
    $USDP
    $VFC
    $VJET
    $VLCN
    Railroads
    Transportation
    Garments and Clothing
    Industrials
    Get the next $USDP alert in real time by email

     

    On Monday, 85 stocks hit new 52-week lows.

    Noteworthy Points From Today's 52-Week Lows:

    • Bristol-Myers Squibb (NYSE:BMY) was the biggest company on a market cap basis to set a new 52-week low.
    • The smallest company by market cap to hit a new 52-week low was Assure Hldgs (NASDAQ:IONM).
    • Adamis Pharmaceuticals (NASDAQ:ADMP) was the biggest loser, trading down 6320.0% to reach its 52-week low.
    • Greystone Housing Impact (NYSE:GHI) shares were the most resilient, as shares rose 0.0%, rebounding from its new 52-week low.

    The following stocks set new 52-week lows on Monday:

    • Bristol-Myers Squibb (NYSE:BMY) stock hit $65.14 on Monday morning, setting a new 52-week low for a change of down 0.52%.
    • Keurig Dr Pepper (NASDAQ:KDP) shares reached a new 52-week low of $31.62 on Monday morning, moving down 0.25%.
    • Dominion Energy (NYSE:D) stock dropped to a yearly low on Monday of $51.69. Shares traded down 0.05%.
    • Walgreens Boots Alliance (NASDAQ:WBA) shares fell to $30.15 on Monday, setting a new 52-week low with a shift of down 2.51%.
    • Alexandria Real Estate (NYSE:ARE) shares set a new yearly low of $114.92 this morning. The stock was down 0.07% on the session.
    • Paramount Global (NASDAQ:PARAA) stock hit a yearly low of $17.07. The stock was down 1.03% for the day.
    • Healthpeak Properties (NYSE:PEAK) stock broke to a new 52-week low of $19.68 on Monday. Shares of the company traded down 0.03%.
    • Paramount Global (NASDAQ:PARA) stock achieved a new 52-week low on Monday morning, hitting $14.77 and moving down 0.92%.
    • VF (NYSE:VFC) stock dropped to a yearly low on Monday of $18.54. Shares traded up 0.42%.
    • H&R Block (NYSE:HRB) stock dropped to a yearly low on Monday of $29.13. Shares traded down 0.76%.
    • Frontier Communications (NASDAQ:FYBR) shares set a new yearly low of $16.50 this morning. The stock was down 1.31% on the session.
    • Newell Brands (NASDAQ:NWL) stock drifted down 0.17% on Monday morning to hit a new 52-week low of $8.52.
    • Lyft (NASDAQ:LYFT) shares fell to $7.97 on Monday, setting a new 52-week low with a shift of up 0.59%.
    • Victoria's Secret (NYSE:VSCO) stock hit a new 52-week low of $24.71. The stock was down 2.44% on the session.
    • Tandem Diabetes Care (NASDAQ:TNDM) shares hit a yearly low of $28.02. The stock was up 4.91% on the session.
    • ZIM Integrated Shipping (NYSE:ZIM) stock hit a new 52-week low of $14.55. The stock was down 14.22% on the session.
    • Silicon Motion Technology (NASDAQ:SIMO) stock drifted down 2.8% on Monday morning to hit a new 52-week low of $51.74.
    • Claros Mortgage Trust (NYSE:CMTG) stock dropped to a yearly low on Monday of $10.21. Shares traded down 3.33%.
    • Revolve Gr (NYSE:RVLV) stock hit $15.55 on Monday morning, setting a new 52-week low for a change of up 0.57%.
    • Perimeter Solutions (NYSE:PRM) shares fell to $6.10 on Monday, setting a new 52-week low with a shift of down 0.89%.
    • Alexander's (NYSE:ALX) stock set a new 52-week low of $160.72 on Monday, moving down 0.44%.
    • AMC Networks (NASDAQ:AMCX) shares made a new 52-week low of $13.23 on Monday. The stock was down 0.75% for the day.
    • Adamis Pharmaceuticals (NASDAQ:ADMP) shares fell to $3.10 on Monday, setting a new 52-week low with a shift of up 6320.0%.
    • Sohu.com (NASDAQ:SOHU) shares moved down 0.9% on Monday to hit a new 52-week low of $12.08, drifting down 0.9%.
    • Greystone Housing Impact (NYSE:GHI) stock achieved a new 52-week low on Monday morning, hitting $15.28 and moving 0.0% (flat).
    • ON24 (NYSE:ONTF) stock set a new 52-week low of $6.89 on Monday, moving down 0.72%.
    • Largo (NASDAQ:LGO) stock set a new 52-week low of $3.83 on Monday, moving down 1.16%.
    • Sportsman's Warehouse (NASDAQ:SPWH) stock set a new 52-week low of $5.76 on Monday, moving down 3.27%.
    • PIMCO CA Muni Income Fund (NYSE:PCK) stock achieved a new 52-week low on Monday morning, hitting $5.86 and moving down 0.17%.
    • Inovio Pharmaceuticals (NASDAQ:INO) stock hit a yearly low of $0.64. The stock was up 0.31% for the day.
    • OneConnect Financial Tech (NYSE:OCFT) shares set a new yearly low of $4.49 this morning. The stock was down 6.42% on the session.
    • Grindrod Shipping Hldgs (NASDAQ:GRIN) stock drifted down 0.98% on Monday morning to hit a new 52-week low of $8.86.
    • Ames National (NASDAQ:ATLO) stock hit a yearly low of $17.73. The stock was down 0.03% for the day.
    • Mullen Automotive (NASDAQ:MULN) stock hit $0.97 on Monday morning, setting a new 52-week low for a change of down 7.08%.
    • OptiNose (NASDAQ:OPTN) stock hit a yearly low of $1.27. The stock was down 10.34% for the day.
    • Sachem Cap (AMEX:SACH) shares set a new yearly low of $3.05 this morning. The stock was down 1.45% on the session.
    • John Hancock Hedged (NYSE:HEQ) stock set a new 52-week low of $10.76 on Monday, moving down 0.28%.
    • Bassett Furniture Indus (NASDAQ:BSET) shares moved down 0.33% on Monday to hit a new 52-week low of $13.66, drifting down 0.33%.
    • Container Store Group (NYSE:TCS) stock drifted up 0.45% on Monday morning to hit a new 52-week low of $2.15.
    • Selina Hospitality (NASDAQ:SLNA) shares set a new 52-week low of $1.01. The stock traded down 0.06%.
    • Peoples Bancorp of NC (NASDAQ:PEBK) shares moved down 6.69% on Monday to hit a new 52-week low of $17.54, drifting down 6.69%.
    • Zapp Electric Vehicles (NASDAQ:ZAPP) stock set a new 52-week low of $2.59 on Monday, moving down 5.11%.
    • Near Intelligence (NASDAQ:NIR) shares were down 4.98% for the day, having made a 52-week low of $1.85.
    • Clough Global Dividend (AMEX:GLV) shares set a new yearly low of $5.37 this morning. The stock was up 0.92% on the session.
    • Etao International Co (NASDAQ:ETAO) stock set a new 52-week low of $0.60 on Monday, moving down 0.33%.
    • USD Partners (NYSE:USDP) shares made a new 52-week low of $1.50 on Monday. The stock was down 1.35% for the day.
    • Rain Oncology (NASDAQ:RAIN) shares fell to $1.11 on Monday, setting a new 52-week low with a shift of down 87.36%.
    • CURO Group Holdings (NYSE:CURO) shares were down 0.91% for the day, having made a 52-week low of $1.06.
    • Trio Petroleum (AMEX:TPET) shares reached a new 52-week low of $1.44 on Monday morning, moving down 5.65%.
    • Vinco Ventures (NASDAQ:BBIG) shares hit a yearly low of $2.02. The stock was up 10.24% on the session.
    • GreenLight Biosciences (NASDAQ:GRNA) stock drifted down 4.61% on Monday morning to hit a new 52-week low of $0.18.
    • Diebold Nixdorf (NYSE:DBD) shares were down 5.71% for the day, having made a 52-week low of $0.31.
    • Cyxtera Technologies (NASDAQ:CYXT) stock set a new 52-week low of $0.14 on Monday, moving down 3.4%.
    • Volcon (NASDAQ:VLCN) shares were down 34.86% for the day, having made a 52-week low of $0.70.
    • Ault Alliance (AMEX:AULT) stock hit $12.04 on Monday morning, setting a new 52-week low for a change of down 17.11%.
    • voxeljet (NASDAQ:VJET) stock dropped to a yearly low on Monday of $1.80. Shares traded down 3.97%.
    • TRACON Pharma (NASDAQ:TCON) stock hit $0.61 on Monday morning, setting a new 52-week low for a change of down 0.59%.
    • Shuttle Pharmaceuticals (NASDAQ:SHPH) shares moved up 0.06% on Monday to hit a new 52-week low of $1.02, drifting up 0.06%.
    • ReTo Eco-Solutions (NASDAQ:RETO) stock hit a yearly low of $2.05. The stock was down 1.4% for the day.
    • Educational Development (NASDAQ:EDUC) shares were down 2.83% for the day, having made a 52-week low of $1.28.
    • Yoshiharu Global (NASDAQ:YOSH) stock dropped to a yearly low on Monday of $0.77. Shares traded up 1.28%.
    • iSun (NASDAQ:ISUN) shares set a new yearly low of $0.47 this morning. The stock was down 2.02% on the session.
    • Palisade Bio (NASDAQ:PALI) shares reached a new 52-week low of $1.42 on Monday morning, moving down 2.02%.
    • AgriFORCE Growing Systems (NASDAQ:AGRI) stock set a new 52-week low of $0.45 on Monday, moving down 5.38%.
    • Surgalign Holdings (NASDAQ:SRGA) stock hit $0.85 on Monday morning, setting a new 52-week low for a change of up 3.06%.
    • SeaStar Medical Holding (NASDAQ:ICU) stock hit a yearly low of $0.55. The stock was 0.0% (flat) for the day.
    • Ascent Solar Technologies (NASDAQ:ASTI) shares reached a new 52-week low of $0.15 on Monday morning, moving down 6.82%.
    • Lexaria Bioscience (NASDAQ:LEXX) shares made a new 52-week low of $0.65 on Monday. The stock was down 8.85% for the day.
    • Bluejay Diagnostics (NASDAQ:BJDX) stock set a new 52-week low of $0.21 on Monday, moving down 23.35%.
    • Staffing 360 Solutions (NASDAQ:STAF) stock hit a new 52-week low of $1.11. The stock was down 2.67% on the session.
    • Micromobility com (NASDAQ:MCOM) stock drifted down 7.35% on Monday morning to hit a new 52-week low of $0.46.
    • First Wave BioPharma (NASDAQ:FWBI) stock dropped to a yearly low on Monday of $2.07. Shares traded down 0.92%.
    • Athenex (NASDAQ:ATNX) stock dropped to a yearly low on Monday of $0.26. Shares traded down 8.86%.
    • ThermoGenesis Holdings (NASDAQ:THMO) stock broke to a new 52-week low of $1.52 on Monday. Shares of the company traded down 6.51%.
    • Baudax Bio (NASDAQ:BXRX) shares reached a new 52-week low of $0.54 on Monday morning, moving down 15.09%.
    • Assure Hldgs (NASDAQ:IONM) shares set a new yearly low of $0.94 this morning. The stock was down 4.72% on the session.

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $USDP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $USDP
    $VFC
    $VJET
    $VLCN

    CompanyDatePrice TargetRatingAnalyst
    Palisade Bio Inc.
    $PALI
    2/25/2026$5.00Buy
    Stifel
    Bristol-Myers Squibb Company
    $BMY
    2/25/2026$60.00Sector Perform
    RBC Capital Mkts
    V.F. Corporation
    $VFC
    2/23/2026$18.00Neutral → Underweight
    Analyst
    Tandem Diabetes Care Inc.
    $TNDM
    2/23/2026$50.00Hold → Buy
    Lake Street
    Bristol-Myers Squibb Company
    $BMY
    2/20/2026$75.00Overweight
    Barclays
    Tandem Diabetes Care Inc.
    $TNDM
    2/20/2026$30.00Underperform → Neutral
    BofA Securities
    Alexandria Real Estate Equities Inc.
    $ARE
    2/3/2026$60.00Neutral
    Goldman
    V.F. Corporation
    $VFC
    1/29/2026$16.00 → $20.00Market Perform
    Telsey Advisory Group
    More analyst ratings

    $USDP
    $VFC
    $VJET
    $VLCN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Stifel initiated coverage on Palisade Bio with a new price target

    Stifel initiated coverage of Palisade Bio with a rating of Buy and set a new price target of $5.00

    2/25/26 7:53:12 AM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    RBC Capital Mkts initiated coverage on Bristol-Myers with a new price target

    RBC Capital Mkts initiated coverage of Bristol-Myers with a rating of Sector Perform and set a new price target of $60.00

    2/25/26 7:49:08 AM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    V.F. Corp downgraded by Analyst with a new price target

    Analyst downgraded V.F. Corp from Neutral to Underweight and set a new price target of $18.00

    2/23/26 8:34:02 AM ET
    $VFC
    Garments and Clothing
    Industrials

    $USDP
    $VFC
    $VJET
    $VLCN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Sachem Capital Sets Dates for Fourth Quarter and Full Year 2025 Earning Release and Conference Call

    BRANFORD, Conn., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Sachem Capital Corp. (NYSE:SACH) (the "Company") announced today that the Company will release its fourth quarter and full year 2025 financial results after market closes on Thursday, March 12, 2026. A webcast and conference call to discuss the results will be held on Friday, March 13, 2026, at 8:00 a.m. Eastern Time. Webcast:A webcast of the conference call will be available on the Investors section of the Company's website www.sachemcapitalcorp.com. To listen to the live broadcast, go to the site at least 15 minutes prior to the scheduled start time to register and install any necessary audio software. To Participate in the Telephone C

    2/26/26 4:15:00 PM ET
    $SACH
    Real Estate Investment Trusts
    Real Estate

    SystImmune and Bristol Myers Squibb Highlight Positive Phase III Interim Topline Results for izalontamab brengitecan (Iza-bren) in Previously Treated Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer

    Izalontamab brengitecan (Iza-bren) met its dual primary endpoints of progression free survival ("PFS") and overall survival ("OS") in an interim analysis of a Phase 3 trial (NCT06382142) conducted in China BL-B01D1-307 is the third Phase III study in which iza-bren has achieved its primary endpoint(s) SystImmune, Inc. (SystImmune), a clinical-stage biotechnology company, and Bristol Myers Squibb (NYSE:BMY) today announced that SystImmune's parent company, Sichuan Biokin Pharmaceutical Co., Ltd. (Biokin), reported positive topline results from a pre-specified interim analysis of a Phase III study (BL-B01D1-307) evaluating izalontamab brengitecan (iza-bren), an EGFR×HER3 bispecific antibo

    2/26/26 6:59:00 AM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Perimeter Solutions Reports Fourth Quarter 2025 Financial Results

    Full year Net Loss of $206.4M and Adjusted Net Income of $206.7M Continued value driver execution drove full year Adjusted EBITDA of $331.7M Full year Loss Per Diluted Share of $1.37 and Adjusted Earnings Per Diluted Share of $1.34 Specialty Products Segment acquired add-on product lines in Q4 2025, and MMT in Q1 2026 CLAYTON, Mo., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Perimeter Solutions, Inc. (NYSE:PRM) ("Perimeter," "Perimeter Solutions," or the "Company"), a leading provider of industrial products and services that support critical and complex customer missions across a range of niche applications, today reported financial results for its fourth quarter, and full year, ended December 3

    2/26/26 6:00:00 AM ET
    $PRM
    Major Chemicals
    Industrials

    $USDP
    $VFC
    $VJET
    $VLCN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Abernethy James S sold $20,350 worth of shares (523 units at $38.91) and gifted 500 shares, decreasing direct ownership by 1% to 70,903 units (SEC Form 4)

    4 - PEOPLES BANCORP OF NORTH CAROLINA INC (0001093672) (Issuer)

    2/27/26 5:04:31 PM ET
    $PEBK
    Major Banks
    Finance

    Officer Llewellyn Lindsay Catherine sold $314,755 worth of shares (23,661 units at $13.30), decreasing direct ownership by 3% to 696,850 units (SEC Form 4)

    4 - Lyft, Inc. (0001759509) (Issuer)

    2/27/26 4:51:21 PM ET
    $LYFT
    Real Estate

    Chief Scientific Officer Humeau Laurent converted options into 12,376 shares and covered exercise/tax liability with 5,098 shares, increasing direct ownership by 22% to 39,900 units (SEC Form 4)

    4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)

    2/27/26 4:49:03 PM ET
    $INO
    Medical/Dental Instruments
    Health Care

    $USDP
    $VFC
    $VJET
    $VLCN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    February 28, 2025 - FDA Roundup: February 28, 2025

    For Immediate Release: February 28, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:On Thursday, the FDA approved Odactra to include use in individuals 5 through 11 years of age to treat house dust mite induced nasal inflammation (allergic rhinitis), with or without eye inflammation (conjunctivitis). Odactra is an allergen extract immunotherapy

    2/28/25 5:00:47 PM ET
    $TNDM
    Medical/Dental Instruments
    Health Care

    September 26, 2024 - FDA Approves Drug with New Mechanism of Action for Treatment of Schizophrenia

    For Immediate Release: September 26, 2024 Today, the U.S. Food and Drug Administration approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults. It is the first antipsychotic drug approved to treat schizophrenia that targets cholinergic receptors as opposed to dopamine receptors, which has long been the standard of care.   “Schizophrenia is a leading

    9/26/24 6:42:20 PM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    June 14, 2024 - FDA Roundup: June 14, 2024

    For Immediate Release: June 14, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued a proposed exemption for certain cottage cheese products from the requirements of the Food Traceability Rule. The proposal would exempt Grade “A” cottage cheese that appears on the Interstate Milk Shippers List from the requirements of the r

    6/14/24 3:54:45 PM ET
    $MMSI
    $BMY
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $USDP
    $VFC
    $VJET
    $VLCN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Cassabaum Michelle R bought $5,586 worth of shares (205 units at $27.25), increasing direct ownership by 2% to 9,734 units (SEC Form 4)

    4 - AMES NATIONAL CORP (0001132651) (Issuer)

    2/27/26 4:38:02 PM ET
    $ATLO
    Major Banks
    Finance

    Director Walter W Edward bought $56,895 worth of shares (25,000 units at $2.28) (SEC Form 4)

    4 - Claros Mortgage Trust, Inc. (0001666291) (Issuer)

    2/26/26 9:11:04 PM ET
    $CMTG
    Real Estate
    Finance

    Chief Executive Officer Risher John David bought $100,179 worth of shares (7,490 units at $13.38), increasing direct ownership by 0.07% to 11,481,792 units (SEC Form 4)

    4 - Lyft, Inc. (0001759509) (Issuer)

    2/18/26 4:10:21 PM ET
    $LYFT
    Real Estate

    $USDP
    $VFC
    $VJET
    $VLCN
    SEC Filings

    View All

    SEC Form 144 filed by Lyft Inc.

    144 - Lyft, Inc. (0001759509) (Subject)

    2/27/26 5:38:52 PM ET
    $LYFT
    Real Estate

    Tandem Diabetes Care Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits

    8-K - TANDEM DIABETES CARE INC (0001438133) (Filer)

    2/27/26 4:06:08 PM ET
    $TNDM
    Medical/Dental Instruments
    Health Care

    SEC Form N-CSR filed by John Hancock Diversified Income Fund

    N-CSR - John Hancock Diversified Income Fund (0001496749) (Filer)

    2/26/26 9:56:16 AM ET
    $HEQ
    Investment Managers
    Finance

    $USDP
    $VFC
    $VJET
    $VLCN
    Leadership Updates

    Live Leadership Updates

    View All

    Palisade Bio Appoints Global IBD Precision Medicine Leader Bram Verstockt, MD, PhD to Clinical Advisory Board

    Appointment strengthens Phase 2 development strategy for PALI-2108 in ulcerative colitis and fibrostenotic Crohn's disease; Phase 2 ulcerative colitis IND submission planned for first half of 2026 Carlsbad, CA, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (NASDAQ:PALI) ("Palisade" or the "Company"), a clinical-stage biopharmaceutical company advancing next-generation, once-daily oral PDE4 inhibitor prodrugs engineered for targeted delivery to the terminal ileum and colon, today announced the appointment of Bram Verstockt, MD, PhD, to its Clinical Advisory Board (CAB). Dr. Verstockt is an internationally recognized expert in inflammatory bowel disease (IBD) and a leader in precisi

    2/17/26 8:45:00 AM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Keurig Dr Pepper Announces New Directors and Governance Changes

    Appoints two highly qualified independent directors to the Board Establishes new Board committees reinforcing strong governance  BURLINGTON, Mass. and FRISCO, Texas, Feb. 12, 2026 /PRNewswire/ -- Keurig Dr Pepper (NASDAQ:KDP) today announced the continued evolution of its Board of Directors. Effective March 2, two new independent directors, Amie Thuener and William "Bill" Newlands, will join the Board. On the same date, the existing Remuneration & Nominating Committee will separate into newly-created Nominating & Governance and Compensation Committees. These changes support KDP's transformation and value creation agenda as it approaches the closing of the JDE Peet's acquisition in early Q2 a

    2/12/26 4:45:00 PM ET
    $KDP
    Beverages (Production/Distribution)
    Consumer Staples

    Palisade Bio Appoints Leading Global IBD Experts, Laurent Peyrin-Biroulet, MD, PhD and David T. Rubin, MD, to Its Clinical Advisory Board

    Internationally recognized leaders in inflammatory bowel disease bring deep expertise spanning ulcerative colitis, Crohn's disease, and late-stage clinical trial design Appointments strengthen Palisade Bio's clinical strategy as PALI-2108 advances toward Phase 2 development in ulcerative colitis and fibrostenotic Crohn's disease, with a Phase 2 UC IND submission planned for the first half of 2026 Carlsbad, CA, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (NASDAQ:PALI) ("Palisade" or the "Company"), a clinical-stage biopharmaceutical company developing next-generation, once-daily, oral PDE4 inhibitor prodrugs designed for targeted delivery to the terminal ileum and colon, today an

    1/29/26 8:45:00 AM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $USDP
    $VFC
    $VJET
    $VLCN
    Financials

    Live finance-specific insights

    View All

    Sachem Capital Sets Dates for Fourth Quarter and Full Year 2025 Earning Release and Conference Call

    BRANFORD, Conn., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Sachem Capital Corp. (NYSE:SACH) (the "Company") announced today that the Company will release its fourth quarter and full year 2025 financial results after market closes on Thursday, March 12, 2026. A webcast and conference call to discuss the results will be held on Friday, March 13, 2026, at 8:00 a.m. Eastern Time. Webcast:A webcast of the conference call will be available on the Investors section of the Company's website www.sachemcapitalcorp.com. To listen to the live broadcast, go to the site at least 15 minutes prior to the scheduled start time to register and install any necessary audio software. To Participate in the Telephone C

    2/26/26 4:15:00 PM ET
    $SACH
    Real Estate Investment Trusts
    Real Estate

    Perimeter Solutions Reports Fourth Quarter 2025 Financial Results

    Full year Net Loss of $206.4M and Adjusted Net Income of $206.7M Continued value driver execution drove full year Adjusted EBITDA of $331.7M Full year Loss Per Diluted Share of $1.37 and Adjusted Earnings Per Diluted Share of $1.34 Specialty Products Segment acquired add-on product lines in Q4 2025, and MMT in Q1 2026 CLAYTON, Mo., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Perimeter Solutions, Inc. (NYSE:PRM) ("Perimeter," "Perimeter Solutions," or the "Company"), a leading provider of industrial products and services that support critical and complex customer missions across a range of niche applications, today reported financial results for its fourth quarter, and full year, ended December 3

    2/26/26 6:00:00 AM ET
    $PRM
    Major Chemicals
    Industrials

    NYSE Content Update: Two MSCI Indexes to Begin Trading on NYSE Arca Options

    NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, Feb. 25, 2026 /CNW/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley Mastronardi delivers the pre-market update on February 25thEquities are higher Wednesday morning as Nvidia prepares to release its fourth quarter earnings after market close.MSCI Emerging Markets Index Options and MSCI EAFE Index Options are set to begin trading on NYSE Arca Options today under the ticker symbols MXEF and MXEADynatrace (NYSE:DT) CEO Rick McConnell will

    2/25/26 8:55:00 AM ET
    $BMY
    $DT
    $ICE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Computer Software: Prepackaged Software
    Technology

    $USDP
    $VFC
    $VJET
    $VLCN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Frontier Communications Parent Inc.

    SC 13D/A - Frontier Communications Parent, Inc. (0000020520) (Subject)

    12/12/24 4:15:11 PM ET
    $FYBR
    Telecommunications Equipment
    Telecommunications

    Amendment: SEC Form SC 13D/A filed by Paramount Global

    SC 13D/A - Paramount Global (0000813828) (Subject)

    12/12/24 4:14:51 PM ET
    $PARAA
    Broadcasting
    Industrials

    SEC Form SC 13G filed by Frontier Communications Parent Inc.

    SC 13G - Frontier Communications Parent, Inc. (0000020520) (Subject)

    12/10/24 10:13:50 AM ET
    $FYBR
    Telecommunications Equipment
    Telecommunications